Skip to main content

Table 3 Recommendations for use of IGRT and other infection prevention strategies for specific causes of SHG [2]

From: Secondary Immunodeficiency

  1. BCTT: B-cell targeted therapy; CAR-T-cell: chimeric antigen receptor T-cell; CLL: chronic lymphocytic leukemia; IGRT: immunoglobulin replacement therapy; IVIG: intravenous immunoglobulin; MM: multiple myeloma; PLE: protein-losing enteropathy; RCTs: randomized controlled trials; SCIG: subcutaneous immunoglobulin; SHG: secondary hypogammaglobulinemia
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us